Femasys Inc $FEMY

What the company doesAI summary of filing

Femasys Inc. is a medical device company that develops and commercializes products for women's reproductive health. The company markets FemaSeed, an FDA-cleared intratubal insemination device for treating infertility, along with companion diagnostics FemVue and FemSperm products; it also markets FemCerv for cervical cancer diagnosis and FemChec for tubal assessment. FemBloc, the company's lead product candidate, is a non-surgical permanent birth control system currently in late-stage clinical development in the U.S. with regulatory approvals already obtained in the EU, UK, and New Zealand. The company generates revenue from commercialized products including FemaSeed, FemVue, and FemCerv, while FemBloc remains in pivotal clinical trials for U.S. FDA approval. [10-K 2026-03-31]

Segments: FemaSeed (intratubal insemination), FemVue/FemVue Controlled (fallopian tube diagnostic), FemBloc (permanent birth control), FemCerv (cervical cancer diagnosis)